Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial by Fennell, Dean A, Ewings, Sean, Ottensmeier, Christian, Califano, Raffaele, Hanna, Gerard G, Hill, Kayleigh, Danson, Sarah, Steele, Nicola, Nye, Mavis, Johnson, Lucy, Lord, Joanne, Middleton, Calley, Szlosarek, Peter, Chan, Sam, Gaba, Aarti, Darlison, Liz, Wells-Jordan, Peter, Richards, Cathy, Poile, Charlotte, Lester, Jason F, Griffiths, Gareth, Price, Gillian, Shaw, Paul, Cave, Judith, Naik, Jay, Ford, Amy, Geldhart, Tom, Dancey, Gairin, Papadatos, Dionysis, Polychronis, Andy, Jankowska, Petra, Scott, Angela, Gardiner, Jill, Cominos, Mathilda, Campbell, Lynn, MacGregor, Carol, Mullholand, Lois, Chitnis, Meenali, Dougherty, Gary

Get full text